遗传学
突变
蛋白脂蛋白1
医学
表型
退行性疾病
肌张力障碍
疾病
等位基因
神经遗传学
生物
基因
病理
髓鞘
内科学
精神科
中枢神经系统
髓鞘碱性蛋白
作者
Marco Henneke,Patricia Combes,Simone Diekmann,Enrico Bertini,Knut Brockmann,Alessandro P. Burlina,Jens Kaiser,Andreas Ohlenbusch,Barbara Plecko,Diana Rodriguez,Odile Boespflüg-Tanguy,Jutta Gärtner
出处
期刊:Neurology
[Ovid Technologies (Wolters Kluwer)]
日期:2007-12-20
卷期号:70 (10): 748-754
被引量:81
标识
DOI:10.1212/01.wnl.0000284828.84464.35
摘要
Background: Pelizaeus-Merzbacher-like disease (PMLD) is a genetically heterogeneous disorder within the group of hypomyelinating leukoencephalopathies. Mutations of the gap junction protein α12 (GJA12) gene are known to cause one autosomal recessive PMLD form. Few patients with GJA12 mutated PMLD have been reported, and to date, the frequency as well as the genotypic and phenotypic spectrum of GJA12 related PMLD is unclear. Methods: We report mutation analysis of the GJA12 gene in a clinical and radiologic well-characterized multiethnic cohort of 193 patients with PMLD from 182 families. Results and Conclusions: Only 16 patients (8.3%) from 14 families (7.7%) carry GJA12 mutations including five families where we detected only one mutated allele. Among those, we identified 11 novel alterations. Thus, GJA12 mutations are a rather rare cause for Pelizaeus-Merzbacher-like disease. The clinical phenotype of patients with a GJA12 mutation was evaluated and is overall comparable to the clinical features seen in mild forms of proteolipid protein 1 (PLP1) related disorder but with better cognition and earlier signs of axonal degeneration.
科研通智能强力驱动
Strongly Powered by AbleSci AI